Ingen Technologies, Inc. Pacific Rim Prepares For Oxyview & Oxyalert

CALIMESA, Calif., Jan. 31 /PRNewswire-FirstCall/ - Ingen Technologies, Inc. , a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that the company has received a proposal from the Tokibo Group to represent the OxyView(TM), OxyAlert(TM) and Secure Balance(TM) in Asia.

The Tokibo Group is a conglomerate of seven companies. Two of the companies, TKB International, Inc. and Newport Medical Instruments, Inc. are located in Costa Mesa, California. Tokibo is the largest independent medical device distributor in Japan and the partner of many prominent US companies such as Cardinal Health, Welch Allyn, Vital Signs and Newport Medical Instruments. Tokibo Co. Hong Kong Ltd is the distributor in Hong Kong and mainland China for many of the same companies.

Due to its strong franchises in the hospital and home care segments, Tokibo is the market leader in the respiratory area in Japan, Hong Kong and China. “We believe that there would be a great deal of synergy between our existing product portfolio and Ingen’s products; and that our installed base of customers would enable us to ramp up sales quickly and steadily.” Said Elizabeth Sanborn, Vice President of Business Development for TKB International, Inc.

“With the increase in share price, revenues and profits, and as we continue to complete all of the necessary SEC filings to move to the OTCBB; I look forward to establishing OxyView(TM) revenues to strengthen our capital structure and build earnings and value for our shareholders and their investment in IGTG.” Said Scott Sand, Chairman and CEO of Ingen Technologies.

About Ingen Technologies, Inc.

Ingen Technologies, Inc. is a public company trading under NASDAQ OTC:IGTG, which has been in business since 1999. IGTG is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products.

The Company’s flagship product is OxyAlert(TM), a second-generation design of the Company’s BAFI(TM) product line. Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001. Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(TM) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.

The newest product, OxyView(TM), has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow for patients in the hospital, surgical room, outpatient therapy, nursing homes and emergency response facilities. This product enhances the safety, assurance and accuracy of patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate near the patient. It could quickly inform the physician or technician of any leak or inaccuracy between the delivery source and the patient.

The Secure Balance(TM) product is a private-label product that includes a vestibular function testing system and balance therapy system. The vestibular function testing system is manufactured by Interacoustics LTD. in Denmark and is referred to as the VNG. The balance therapy system is manufactured by SportKAT(R), Inc. in San Diego, California. The Secure Balance(TM) program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.

The Pure Produce(TM) product is a continuing research & development program currently under design. This program uses hydroponics technology to grow various plants without the use of soil, fertilizer and water consumption. The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.

“Our team of professionals has developed our medical products for the ever-increasing elderly population. Our products are superior to any of our competition and they allow for effective medical product availability to seniors, and at the same time the increasing senior population allows for a steady growth in sales and profits,” said Scott Sand, CEO & Chairman of Ingen Technologies.

For more information, visit www.ingen-tech.com Investor Relations Contact: Scott R. Sand, C.E.O & Chairman Ingen Technologies, Inc. - Administrative Office 35193 Avenue “A”, Suite-CYucaipa, California 92399 Phone: (800) 259-9622 or (909) 790-7180 Fax: (800) 777-1186 or (909) 795-6340 Email: Info@ingen-tech.com A Member of the Better Business Bureau A Member of the Chamber of Commerce A Licensed Business in the City of Yucaipa

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements that are made pursuant to “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.

Ingen Technologies, Inc.

CONTACT: Scott R. Sand, C.E.O & Chairman of Ingen Technologies, Inc.,+1-800-259-9622, or +1-909-790-7180, or Fax: +1-800-777-1186 or+1-909-795-6340, Info@ingen-tech.com

MORE ON THIS TOPIC